These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25741972)

  • 1. Changing trends of acute otitis media bacteriology in central Israel in the pneumococcal conjugate vaccines era.
    Tamir SO; Roth Y; Dalal I; Goldfarb A; Grotto I; Marom T
    Pediatr Infect Dis J; 2015 Feb; 34(2):195-9. PubMed ID: 25741972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal acute otitis media in infants and children in central Romania, 2009-2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines.
    Falup-Pecurariu O; Leibovitz E; Mercas A; Bleotu L; Zavarache C; Porat N; Dagan R; Greenberg D
    Int J Infect Dis; 2013 Sep; 17(9):e702-6. PubMed ID: 23522635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
    Casey JR; Adlowitz DG; Pichichero ME
    Pediatr Infect Dis J; 2010 Apr; 29(4):304-9. PubMed ID: 19935445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of pneumococcal versus non-pneumococcal acute otitis media in children.
    Ovnat Tamir S; Roth Y; Goldfarb A; Grotto I; Marom T
    Clin Otolaryngol; 2015 Aug; 40(4):370-7. PubMed ID: 25644105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pneumococcal conjugate vaccines on incidence and microbiology associated with complicated acute otitis media.
    Laursen BB; Danstrup CS; Hoffmann S; Nørskov-Lauritsen N; Christensen ALB; Ovesen T
    Int J Pediatr Otorhinolaryngol; 2017 Oct; 101():249-253. PubMed ID: 28964304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.
    Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R
    Clin Infect Dis; 2014 Dec; 59(12):1724-32. PubMed ID: 25159581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study.
    Pichichero M; Kaur R; Scott DA; Gruber WC; Trammel J; Almudevar A; Center KJ
    Lancet Child Adolesc Health; 2018 Aug; 2(8):561-568. PubMed ID: 30119715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis.
    Ben-Shimol S; Givon-Lavi N; Leibovitz E; Greenberg D; Dagan R
    Vaccine; 2019 Jan; 37(1):1-6. PubMed ID: 30497832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.
    Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R
    Clin Infect Dis; 2016 Sep; 63(5):611-8. PubMed ID: 27225239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.
    Block SL; Hedrick J; Harrison CJ; Tyler R; Smith A; Findlay R; Keegan E
    Pediatr Infect Dis J; 2004 Sep; 23(9):829-33. PubMed ID: 15361721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial etiology of acute otitis media in Spain in the post-pneumococcal conjugate vaccine era].
    Pumarola F; Salamanca de la Cueva I; Sistiaga-Hernando A; García-Corbeira P; Moraga-Llop FA; Cardelús S; McCoig C; Gómez Martínez JR; Rosell Ferrer R; Iniesta Turpin J; Devadiga R
    An Pediatr (Barc); 2016 Nov; 85(5):224-231. PubMed ID: 26969247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany.
    van der Linden M; Imöhl M; Busse A; Rose M; Adam D
    Eur J Pediatr; 2015 Mar; 174(3):355-64. PubMed ID: 25169065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two decades of otitis media in northern Israel: Changing trends in the offending bacteria and antibiotic susceptibility.
    Paker M; Pichkhadze E; Miron D; Shlizerman L; Mazzawi S; Shupak A
    Int J Pediatr Otorhinolaryngol; 2022 Jan; 152():110940. PubMed ID: 34810003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015-2019.
    Kaur R; Fuji N; Pichichero ME
    Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):37-44. PubMed ID: 34432166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines.
    Ziv O; Kraus M; Holcberg R; Dinur AB; Kordeluk S; Kaplan D; Rosenblatt HN; Ben-Shimol S; Greenberg D; Leibovitz E
    Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():123-130. PubMed ID: 30703661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.